Log in to save to my catalogue

Lipopolysaccharide-binding protein and future Parkinson’s disease risk: a European prospective cohor...

Lipopolysaccharide-binding protein and future Parkinson’s disease risk: a European prospective cohor...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2962f05fe2fc4dd3bda9fce1be26ad3b

Lipopolysaccharide-binding protein and future Parkinson’s disease risk: a European prospective cohort

About this item

Full title

Lipopolysaccharide-binding protein and future Parkinson’s disease risk: a European prospective cohort

Publisher

England: BioMed Central Ltd

Journal title

Journal of neuroinflammation, 2023-07, Vol.20 (1), p.170-8, Article 170

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Lipopolysaccharide (LPS) is the outer membrane component of Gram-negative bacteria. LPS-binding protein (LBP) is an acute-phase reactant that mediates immune responses triggered by LPS and has been used as a blood marker for LPS. LBP has recently been indicated to be associated with Parkinson's disease (PD) in small-scale retrospective case-control...

Alternative Titles

Full title

Lipopolysaccharide-binding protein and future Parkinson’s disease risk: a European prospective cohort

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2962f05fe2fc4dd3bda9fce1be26ad3b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2962f05fe2fc4dd3bda9fce1be26ad3b

Other Identifiers

ISSN

1742-2094

E-ISSN

1742-2094

DOI

10.1186/s12974-023-02846-2

How to access this item